Navigation Links
Uptake Medical Names J.C. MacRae as Chief Financial Officer

IRVINE, Calif., Nov. 16, 2010 /PRNewswire/ -- Uptake Medical Corp., the leading developer of medical technologies for interventional emphysema therapy, announced today that J.C. MacRae has joined the company as its vice president and chief financial officer.

MacRae comes to Uptake Medical with over 25 years experience in the medical specialty device and biopharmaceutical product industries. He most recently was a member of the senior management team at CoreValve, Inc., a catheter-based heart valve replacement company, recently acquired by Medtronic (MDT-NYSE), serving as chief financial officer and managing director of CoreValve Europe, BV. During his career to date, MacRae has held senior general and financial management positions with innovative medical product companies and has led three successful IPOs and numerous private financings, and has a broad range of experience that includes initial product launches worldwide, business development, product licensing, and mergers and acquisitions. MacRae graduated from University of California, Irvine and has a MBA from California State University, Fullerton.

Uptake Medical is developing the InterVapor System, a minimally invasive method of treating emphysematous lung tissue. InterVapor delivers thermal vapor to the diseased areas, reducing the lung volume, expanding breathing capacity and improving overall breathing mechanics. The InterVapor System employs a bronchoscopic vapor delivery catheter and vapor generator plus an individualized patient procedure program called IP3 that customizes the treatment to each patient's physiology and condition.

"We are excited to have J.C. join Uptake Medical with his extensive global financial and medical device industry experience. His direct experience and leadership in assisting medical technology companies achieve growth and profitability will be directly applicable to Uptake's near term plans including global expansion, manufacturing scale-up, international distribution and fundraising," noted King Nelson, president and chief executive officer of Uptake Medical.

About Uptake Medical

Uptake Medical™ Corp. is a developer of proprietary medical technologies for the treatment of lung diseases including emphysema. The company's core technology is InterVapor, a simple, minimally invasive, non-implantable interventional pulmonary therapy designed to measurably improve lung function and patient quality of life. More information and a list of participating clinical trial sites can be found at

SOURCE Uptake Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in 2019
2. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
3. The Continued Uptake of Key Agents Such as Januvia, Bydureon and Byetta Will Drive The Type 2 Diabetes Drug Market to Nearly Double From $19 Billion in 2009 to $36 Billion in 2019
4. Argon Medical Devices Announces Exclusive License and Distribution Agreement for UltraStream™ Chronic Hemodialysis Catheter
5. Reportlinker Adds Global Medical Specialty Bags Industry
6. Dehaier Medical Announces Third Quarter 2010 Financial Results
7. Winner Medical Announces Preliminary Fiscal Fourth Quarter 2010 Results
8. Reprints Desk Bolsters Ultra-Rapid Document Delivery Service Through New Electronic Sourcing Agreement with the American Medical Association, Publisher of JAMA & Archives Journals
9. Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010
10. Dehaier Medical Announces Conference Call to Discuss Third Quarter 2010 Financial Results
11. MedClean Technologies Signs Contract with Gamma HealthCare Inc./Danner Medical Waste for MedClean 4500 Fixed-Based System, Services, and Consumables
Post Your Comments:
(Date:11/26/2015)... 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ... kidney transplantation is expected to boost the market growth, as ... transplantation. --> 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ...
(Date:11/26/2015)... 2015 ) ... "2016 Future Horizons and Growth Strategies in ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> ) has announced ... Horizons and Growth Strategies in the German ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley from Vintage ... style concert posters. This is one of Joplin's most famous and beautiful concert posters. ... University of Michigan in Ann Arbor. The According to Hawley, "It is hard to ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they also think ... during the Black Friday and Cyber Monday massage chair sales to receive ... high and low to find the best massage chair deals, they can see all ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... opinion process, participated in the 61st annual Employee Benefits Conference. The Employee Benefits ... place Sunday, November 8th through Wednesday, November 11th, 2015. The conference was held ...
Breaking Medicine News(10 mins):